nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxepin—DRD2—nicotine dependence	0.623	1	CbGaD
Doxepin—ORM1—saliva—nicotine dependence	0.00902	0.185	CbGeAlD
Doxepin—Haematochezia—Varenicline—nicotine dependence	0.00545	0.0275	CcSEcCtD
Doxepin—Withdrawal symptom—Varenicline—nicotine dependence	0.00535	0.027	CcSEcCtD
Doxepin—Aphthous stomatitis—Varenicline—nicotine dependence	0.00468	0.0236	CcSEcCtD
Doxepin—Drug withdrawal syndrome—Varenicline—nicotine dependence	0.00448	0.0226	CcSEcCtD
Doxepin—Sinus congestion—Varenicline—nicotine dependence	0.00441	0.0223	CcSEcCtD
Doxepin—Extrapyramidal symptoms—Varenicline—nicotine dependence	0.00423	0.0214	CcSEcCtD
Doxepin—Suicide—Varenicline—nicotine dependence	0.00423	0.0214	CcSEcCtD
Doxepin—Suicide attempt—Varenicline—nicotine dependence	0.00387	0.0195	CcSEcCtD
Doxepin—Completed suicide—Varenicline—nicotine dependence	0.00374	0.0188	CcSEcCtD
Doxepin—Cyst—Varenicline—nicotine dependence	0.00329	0.0166	CcSEcCtD
Doxepin—Pharyngolaryngeal pain—Varenicline—nicotine dependence	0.00325	0.0164	CcSEcCtD
Doxepin—Laryngeal pain—Varenicline—nicotine dependence	0.00322	0.0163	CcSEcCtD
Doxepin—Delusion—Varenicline—nicotine dependence	0.0031	0.0157	CcSEcCtD
Doxepin—Extrapyramidal disorder—Varenicline—nicotine dependence	0.00292	0.0147	CcSEcCtD
Doxepin—Fungal infection—Varenicline—nicotine dependence	0.00284	0.0143	CcSEcCtD
Doxepin—Mydriasis—Varenicline—nicotine dependence	0.00275	0.0139	CcSEcCtD
Doxepin—Rhinorrhoea—Varenicline—nicotine dependence	0.00271	0.0137	CcSEcCtD
Doxepin—HRH2—cardiovascular system—nicotine dependence	0.00259	0.053	CbGeAlD
Doxepin—Disturbance in attention—Varenicline—nicotine dependence	0.00254	0.0128	CcSEcCtD
Doxepin—Aggression—Varenicline—nicotine dependence	0.0025	0.0126	CcSEcCtD
Doxepin—Gastrooesophageal reflux disease—Varenicline—nicotine dependence	0.00243	0.0123	CcSEcCtD
Doxepin—Viral infection—Varenicline—nicotine dependence	0.00243	0.0123	CcSEcCtD
Doxepin—Ventricular extrasystoles—Varenicline—nicotine dependence	0.00243	0.0123	CcSEcCtD
Doxepin—Thinking abnormal—Varenicline—nicotine dependence	0.0024	0.0121	CcSEcCtD
Doxepin—Lacrimation increased—Varenicline—nicotine dependence	0.00238	0.012	CcSEcCtD
Doxepin—Nocturia—Varenicline—nicotine dependence	0.00237	0.0119	CcSEcCtD
Doxepin—Blood pressure increased—Varenicline—nicotine dependence	0.0022	0.0111	CcSEcCtD
Doxepin—Abnormal dreams—Varenicline—nicotine dependence	0.00217	0.0109	CcSEcCtD
Doxepin—Hyperkalaemia—Varenicline—nicotine dependence	0.00216	0.0109	CcSEcCtD
Doxepin—Nightmare—Varenicline—nicotine dependence	0.00212	0.0107	CcSEcCtD
Doxepin—Mental disability—Varenicline—nicotine dependence	0.00191	0.00961	CcSEcCtD
Doxepin—Deafness—Varenicline—nicotine dependence	0.00178	0.00899	CcSEcCtD
Doxepin—Disorientation—Varenicline—nicotine dependence	0.00178	0.00899	CcSEcCtD
Doxepin—Eczema—Varenicline—nicotine dependence	0.00177	0.00895	CcSEcCtD
Doxepin—Eye pain—Varenicline—nicotine dependence	0.00177	0.00891	CcSEcCtD
Doxepin—Libido decreased—Varenicline—nicotine dependence	0.00172	0.00867	CcSEcCtD
Doxepin—Hot flush—Varenicline—nicotine dependence	0.0017	0.0086	CcSEcCtD
Doxepin—Increased appetite—Varenicline—nicotine dependence	0.0017	0.00856	CcSEcCtD
Doxepin—CHRM2—cardiovascular system—nicotine dependence	0.0017	0.0348	CbGeAlD
Doxepin—Menopausal symptoms—Varenicline—nicotine dependence	0.00169	0.00852	CcSEcCtD
Doxepin—Lethargy—Varenicline—nicotine dependence	0.00163	0.00821	CcSEcCtD
Doxepin—Cerebrovascular accident—Varenicline—nicotine dependence	0.00163	0.00821	CcSEcCtD
Doxepin—Disturbance in sexual arousal—Varenicline—nicotine dependence	0.00158	0.00798	CcSEcCtD
Doxepin—Migraine—Varenicline—nicotine dependence	0.00157	0.00791	CcSEcCtD
Doxepin—Psychotic disorder—Varenicline—nicotine dependence	0.00156	0.00785	CcSEcCtD
Doxepin—CHRM4—brain—nicotine dependence	0.00155	0.0318	CbGeAlD
Doxepin—CHRM1—cardiovascular system—nicotine dependence	0.00154	0.0316	CbGeAlD
Doxepin—HTR2B—cardiovascular system—nicotine dependence	0.00154	0.0315	CbGeAlD
Doxepin—Urinary retention—Varenicline—nicotine dependence	0.00152	0.00765	CcSEcCtD
Doxepin—Hypokalaemia—Varenicline—nicotine dependence	0.00145	0.00732	CcSEcCtD
Doxepin—Breast disorder—Varenicline—nicotine dependence	0.00144	0.00727	CcSEcCtD
Doxepin—Cramp muscle—Varenicline—nicotine dependence	0.00144	0.00724	CcSEcCtD
Doxepin—Nasopharyngitis—Varenicline—nicotine dependence	0.00143	0.00719	CcSEcCtD
Doxepin—HTR6—brain—nicotine dependence	0.00139	0.0284	CbGeAlD
Doxepin—Asthma—Varenicline—nicotine dependence	0.00138	0.00695	CcSEcCtD
Doxepin—HTR1A—cardiovascular system—nicotine dependence	0.00138	0.0282	CbGeAlD
Doxepin—Bronchitis—Varenicline—nicotine dependence	0.00133	0.00668	CcSEcCtD
Doxepin—HTR2C—midbrain—nicotine dependence	0.00128	0.0262	CbGeAlD
Doxepin—Pollakiuria—Varenicline—nicotine dependence	0.00127	0.00642	CcSEcCtD
Doxepin—Erectile dysfunction—Varenicline—nicotine dependence	0.00127	0.0064	CcSEcCtD
Doxepin—HRH2—brain—nicotine dependence	0.00127	0.026	CbGeAlD
Doxepin—ADRA1A—cardiovascular system—nicotine dependence	0.00127	0.026	CbGeAlD
Doxepin—Weight increased—Varenicline—nicotine dependence	0.00125	0.00632	CcSEcCtD
Doxepin—Infestation—Varenicline—nicotine dependence	0.00123	0.0062	CcSEcCtD
Doxepin—Infestation NOS—Varenicline—nicotine dependence	0.00123	0.0062	CcSEcCtD
Doxepin—KCNH2—cardiovascular system—nicotine dependence	0.00122	0.0251	CbGeAlD
Doxepin—CHRM5—brain—nicotine dependence	0.00121	0.0248	CbGeAlD
Doxepin—SLC6A4—midbrain—nicotine dependence	0.00121	0.0248	CbGeAlD
Doxepin—Stomatitis—Varenicline—nicotine dependence	0.0012	0.00604	CcSEcCtD
Doxepin—Hepatobiliary disease—Varenicline—nicotine dependence	0.00116	0.00586	CcSEcCtD
Doxepin—Sinusitis—Varenicline—nicotine dependence	0.00115	0.00581	CcSEcCtD
Doxepin—Bradycardia—Varenicline—nicotine dependence	0.00112	0.00566	CcSEcCtD
Doxepin—ADRA1B—brain—nicotine dependence	0.00111	0.0227	CbGeAlD
Doxepin—Hypoaesthesia—Varenicline—nicotine dependence	0.0011	0.00553	CcSEcCtD
Doxepin—Hallucination—Varenicline—nicotine dependence	0.0011	0.00553	CcSEcCtD
Doxepin—Urinary tract disorder—Varenicline—nicotine dependence	0.00109	0.00549	CcSEcCtD
Doxepin—Oedema peripheral—Varenicline—nicotine dependence	0.00109	0.00548	CcSEcCtD
Doxepin—Connective tissue disorder—Varenicline—nicotine dependence	0.00108	0.00547	CcSEcCtD
Doxepin—ADRA1D—brain—nicotine dependence	0.00108	0.0222	CbGeAlD
Doxepin—Urethral disorder—Varenicline—nicotine dependence	0.00108	0.00545	CcSEcCtD
Doxepin—HTR1A—midbrain—nicotine dependence	0.00107	0.022	CbGeAlD
Doxepin—Eye disorder—Varenicline—nicotine dependence	0.00103	0.0052	CcSEcCtD
Doxepin—Tinnitus—Varenicline—nicotine dependence	0.00103	0.00519	CcSEcCtD
Doxepin—Cardiac disorder—Varenicline—nicotine dependence	0.00102	0.00516	CcSEcCtD
Doxepin—Angiopathy—Varenicline—nicotine dependence	0.001	0.00505	CcSEcCtD
Doxepin—Immune system disorder—Varenicline—nicotine dependence	0.000996	0.00502	CcSEcCtD
Doxepin—CYP2C9—cardiovascular system—nicotine dependence	0.000995	0.0204	CbGeAlD
Doxepin—Mediastinal disorder—Varenicline—nicotine dependence	0.000994	0.00501	CcSEcCtD
Doxepin—Chills—Varenicline—nicotine dependence	0.00099	0.00499	CcSEcCtD
Doxepin—Arrhythmia—Varenicline—nicotine dependence	0.000985	0.00497	CcSEcCtD
Doxepin—DRD2—midbrain—nicotine dependence	0.000971	0.0199	CbGeAlD
Doxepin—Mental disorder—Varenicline—nicotine dependence	0.000966	0.00487	CcSEcCtD
Doxepin—Malnutrition—Varenicline—nicotine dependence	0.00096	0.00484	CcSEcCtD
Doxepin—Erythema—Varenicline—nicotine dependence	0.00096	0.00484	CcSEcCtD
Doxepin—KCNH2—midbrain—nicotine dependence	0.000956	0.0196	CbGeAlD
Doxepin—Flatulence—Varenicline—nicotine dependence	0.000946	0.00477	CcSEcCtD
Doxepin—ADRA2C—midbrain—nicotine dependence	0.000944	0.0193	CbGeAlD
Doxepin—Dysgeusia—Varenicline—nicotine dependence	0.00094	0.00474	CcSEcCtD
Doxepin—Back pain—Varenicline—nicotine dependence	0.000929	0.00468	CcSEcCtD
Doxepin—Muscle spasms—Varenicline—nicotine dependence	0.000923	0.00466	CcSEcCtD
Doxepin—Vision blurred—Varenicline—nicotine dependence	0.000905	0.00456	CcSEcCtD
Doxepin—Tremor—Varenicline—nicotine dependence	0.000899	0.00454	CcSEcCtD
Doxepin—Ill-defined disorder—Varenicline—nicotine dependence	0.000891	0.00449	CcSEcCtD
Doxepin—Anaemia—Varenicline—nicotine dependence	0.000887	0.00448	CcSEcCtD
Doxepin—Agitation—Varenicline—nicotine dependence	0.000882	0.00445	CcSEcCtD
Doxepin—Malaise—Varenicline—nicotine dependence	0.000866	0.00437	CcSEcCtD
Doxepin—Vertigo—Varenicline—nicotine dependence	0.000863	0.00435	CcSEcCtD
Doxepin—Syncope—Varenicline—nicotine dependence	0.000861	0.00434	CcSEcCtD
Doxepin—Palpitations—Varenicline—nicotine dependence	0.000848	0.00428	CcSEcCtD
Doxepin—Loss of consciousness—Varenicline—nicotine dependence	0.000844	0.00426	CcSEcCtD
Doxepin—Cough—Varenicline—nicotine dependence	0.000838	0.00423	CcSEcCtD
Doxepin—CHRM2—brain—nicotine dependence	0.000832	0.0171	CbGeAlD
Doxepin—Convulsion—Varenicline—nicotine dependence	0.000832	0.0042	CcSEcCtD
Doxepin—Hypertension—Varenicline—nicotine dependence	0.000829	0.00418	CcSEcCtD
Doxepin—HTR2A—cardiovascular system—nicotine dependence	0.00082	0.0168	CbGeAlD
Doxepin—Arthralgia—Varenicline—nicotine dependence	0.000817	0.00412	CcSEcCtD
Doxepin—Myalgia—Varenicline—nicotine dependence	0.000817	0.00412	CcSEcCtD
Doxepin—Chest pain—Varenicline—nicotine dependence	0.000817	0.00412	CcSEcCtD
Doxepin—Anxiety—Varenicline—nicotine dependence	0.000815	0.00411	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.000812	0.00409	CcSEcCtD
Doxepin—Discomfort—Varenicline—nicotine dependence	0.000808	0.00407	CcSEcCtD
Doxepin—HTR2C—brain—nicotine dependence	0.000802	0.0164	CbGeAlD
Doxepin—Dry mouth—Varenicline—nicotine dependence	0.000799	0.00403	CcSEcCtD
Doxepin—Oedema—Varenicline—nicotine dependence	0.000784	0.00395	CcSEcCtD
Doxepin—Infection—Varenicline—nicotine dependence	0.000778	0.00393	CcSEcCtD
Doxepin—Shock—Varenicline—nicotine dependence	0.000771	0.00389	CcSEcCtD
Doxepin—Nervous system disorder—Varenicline—nicotine dependence	0.000768	0.00388	CcSEcCtD
Doxepin—Thrombocytopenia—Varenicline—nicotine dependence	0.000767	0.00387	CcSEcCtD
Doxepin—Tachycardia—Varenicline—nicotine dependence	0.000765	0.00386	CcSEcCtD
Doxepin—Skin disorder—Varenicline—nicotine dependence	0.000761	0.00384	CcSEcCtD
Doxepin—SLC6A4—brain—nicotine dependence	0.00076	0.0156	CbGeAlD
Doxepin—Hyperhidrosis—Varenicline—nicotine dependence	0.000757	0.00382	CcSEcCtD
Doxepin—CHRM1—brain—nicotine dependence	0.000757	0.0155	CbGeAlD
Doxepin—HTR2B—brain—nicotine dependence	0.000753	0.0154	CbGeAlD
Doxepin—ADRA2A—midbrain—nicotine dependence	0.000753	0.0154	CbGeAlD
Doxepin—Anorexia—Varenicline—nicotine dependence	0.000747	0.00377	CcSEcCtD
Doxepin—Hypotension—Varenicline—nicotine dependence	0.000732	0.00369	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.000714	0.0036	CcSEcCtD
Doxepin—Insomnia—Varenicline—nicotine dependence	0.000709	0.00357	CcSEcCtD
Doxepin—Dyspnoea—Varenicline—nicotine dependence	0.000699	0.00352	CcSEcCtD
Doxepin—Somnolence—Varenicline—nicotine dependence	0.000697	0.00351	CcSEcCtD
Doxepin—Dyspepsia—Varenicline—nicotine dependence	0.00069	0.00348	CcSEcCtD
Doxepin—Decreased appetite—Varenicline—nicotine dependence	0.000681	0.00344	CcSEcCtD
Doxepin—CHRM3—brain—nicotine dependence	0.000678	0.0139	CbGeAlD
Doxepin—Gastrointestinal disorder—Varenicline—nicotine dependence	0.000676	0.00341	CcSEcCtD
Doxepin—Fatigue—Varenicline—nicotine dependence	0.000676	0.00341	CcSEcCtD
Doxepin—HTR1A—brain—nicotine dependence	0.000675	0.0138	CbGeAlD
Doxepin—Pain—Varenicline—nicotine dependence	0.00067	0.00338	CcSEcCtD
Doxepin—Constipation—Varenicline—nicotine dependence	0.00067	0.00338	CcSEcCtD
Doxepin—SLC6A2—brain—nicotine dependence	0.000669	0.0137	CbGeAlD
Doxepin—Feeling abnormal—Varenicline—nicotine dependence	0.000646	0.00326	CcSEcCtD
Doxepin—Gastrointestinal pain—Varenicline—nicotine dependence	0.000641	0.00323	CcSEcCtD
Doxepin—HTR2A—midbrain—nicotine dependence	0.00064	0.0131	CbGeAlD
Doxepin—Thiothixene—DRD2—nicotine dependence	0.000623	0.137	CrCbGaD
Doxepin—Urticaria—Varenicline—nicotine dependence	0.000622	0.00314	CcSEcCtD
Doxepin—ADRA1A—brain—nicotine dependence	0.000622	0.0128	CbGeAlD
Doxepin—Abdominal pain—Varenicline—nicotine dependence	0.000619	0.00312	CcSEcCtD
Doxepin—Body temperature increased—Varenicline—nicotine dependence	0.000619	0.00312	CcSEcCtD
Doxepin—DRD2—brain—nicotine dependence	0.00061	0.0125	CbGeAlD
Doxepin—Amitriptyline—OPRM1—nicotine dependence	0.00061	0.134	CrCbGaD
Doxepin—KCNH2—brain—nicotine dependence	0.000601	0.0123	CbGeAlD
Doxepin—ADRA2C—brain—nicotine dependence	0.000593	0.0122	CbGeAlD
Doxepin—Hypersensitivity—Varenicline—nicotine dependence	0.000577	0.00291	CcSEcCtD
Doxepin—Asthenia—Varenicline—nicotine dependence	0.000562	0.00284	CcSEcCtD
Doxepin—Pruritus—Varenicline—nicotine dependence	0.000554	0.0028	CcSEcCtD
Doxepin—ABCB1—cardiovascular system—nicotine dependence	0.000537	0.011	CbGeAlD
Doxepin—Diarrhoea—Varenicline—nicotine dependence	0.000536	0.0027	CcSEcCtD
Doxepin—Dizziness—Varenicline—nicotine dependence	0.000518	0.00261	CcSEcCtD
Doxepin—Vomiting—Varenicline—nicotine dependence	0.000498	0.00251	CcSEcCtD
Doxepin—Rash—Varenicline—nicotine dependence	0.000494	0.00249	CcSEcCtD
Doxepin—Dermatitis—Varenicline—nicotine dependence	0.000494	0.00249	CcSEcCtD
Doxepin—Headache—Varenicline—nicotine dependence	0.000491	0.00248	CcSEcCtD
Doxepin—Chlorprothixene—DRD2—nicotine dependence	0.000491	0.108	CrCbGaD
Doxepin—HRH1—brain—nicotine dependence	0.000482	0.00987	CbGeAlD
Doxepin—Nortriptyline—DRD2—nicotine dependence	0.000482	0.106	CrCbGaD
Doxepin—ADRA2A—brain—nicotine dependence	0.000473	0.0097	CbGeAlD
Doxepin—Nausea—Varenicline—nicotine dependence	0.000465	0.00235	CcSEcCtD
Doxepin—Trimipramine—DRD2—nicotine dependence	0.000453	0.0997	CrCbGaD
Doxepin—Promethazine—DRD2—nicotine dependence	0.000437	0.096	CrCbGaD
Doxepin—ABCB1—midbrain—nicotine dependence	0.00042	0.0086	CbGeAlD
Doxepin—HTR2A—brain—nicotine dependence	0.000402	0.00825	CbGeAlD
Doxepin—Desipramine—DRD2—nicotine dependence	0.000396	0.0872	CrCbGaD
Doxepin—Promazine—DRD2—nicotine dependence	0.000384	0.0845	CrCbGaD
Doxepin—CYP2D6—brain—nicotine dependence	0.000366	0.00751	CbGeAlD
Doxepin—Imipramine—DRD2—nicotine dependence	0.000336	0.074	CrCbGaD
Doxepin—Amitriptyline—DRD2—nicotine dependence	0.000334	0.0735	CrCbGaD
Doxepin—ABCB1—brain—nicotine dependence	0.000264	0.0054	CbGeAlD
Doxepin—CHRM5—Signaling Pathways—TAS2R16—nicotine dependence	0.000104	0.000827	CbGpPWpGaD
Doxepin—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000103	0.000821	CbGpPWpGaD
Doxepin—HTR2A—GPCR ligand binding—OPRM1—nicotine dependence	0.000102	0.000814	CbGpPWpGaD
Doxepin—HRH1—GPCR ligand binding—OPRM1—nicotine dependence	0.000102	0.000813	CbGpPWpGaD
Doxepin—CHRM1—GPCR ligand binding—OPRM1—nicotine dependence	0.000101	0.00081	CbGpPWpGaD
Doxepin—CHRM3—GPCR ligand binding—OPRM1—nicotine dependence	0.000101	0.000807	CbGpPWpGaD
Doxepin—CHRM2—GPCR ligand binding—OPRM1—nicotine dependence	0.0001	0.0008	CbGpPWpGaD
Doxepin—ADRA1A—GPCR ligand binding—OPRM1—nicotine dependence	9.99e-05	0.000797	CbGpPWpGaD
Doxepin—HRH4—Signaling by GPCR—DRD2—nicotine dependence	9.96e-05	0.000794	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—FGD1—nicotine dependence	9.91e-05	0.000791	CbGpPWpGaD
Doxepin—ADRA1D—GPCR ligand binding—DRD2—nicotine dependence	9.8e-05	0.000782	CbGpPWpGaD
Doxepin—ADRA2A—GPCR downstream signaling—FGD1—nicotine dependence	9.77e-05	0.000779	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—FGD1—nicotine dependence	9.75e-05	0.000778	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—TAS2R16—nicotine dependence	9.75e-05	0.000778	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—FGD1—nicotine dependence	9.73e-05	0.000776	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—FGD1—nicotine dependence	9.7e-05	0.000774	CbGpPWpGaD
Doxepin—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	9.69e-05	0.000773	CbGpPWpGaD
Doxepin—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	9.67e-05	0.000771	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—FGD1—nicotine dependence	9.66e-05	0.000771	CbGpPWpGaD
Doxepin—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	9.64e-05	0.000769	CbGpPWpGaD
Doxepin—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	9.61e-05	0.000767	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—FGD1—nicotine dependence	9.57e-05	0.000764	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—FGD1—nicotine dependence	9.54e-05	0.000762	CbGpPWpGaD
Doxepin—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	9.51e-05	0.000759	CbGpPWpGaD
Doxepin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	9.49e-05	0.000757	CbGpPWpGaD
Doxepin—HRH4—Signaling Pathways—WASF2—nicotine dependence	9.42e-05	0.000752	CbGpPWpGaD
Doxepin—ADRA2A—GPCR ligand binding—OPRM1—nicotine dependence	9.28e-05	0.000741	CbGpPWpGaD
Doxepin—HRH4—Signaling Pathways—WASF1—nicotine dependence	9.03e-05	0.000721	CbGpPWpGaD
Doxepin—HTR6—GPCR downstream signaling—OPRM1—nicotine dependence	9.02e-05	0.00072	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—FGD1—nicotine dependence	9e-05	0.000719	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—FGD1—nicotine dependence	8.87e-05	0.000708	CbGpPWpGaD
Doxepin—ADRA2B—GPCR ligand binding—DRD2—nicotine dependence	8.85e-05	0.000706	CbGpPWpGaD
Doxepin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	8.81e-05	0.000703	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—TAS2R16—nicotine dependence	8.8e-05	0.000702	CbGpPWpGaD
Doxepin—HTR1A—GPCR ligand binding—DRD2—nicotine dependence	8.54e-05	0.000682	CbGpPWpGaD
Doxepin—CHRM4—GPCR downstream signaling—OPRM1—nicotine dependence	8.51e-05	0.000679	CbGpPWpGaD
Doxepin—HRH2—GPCR downstream signaling—DRD2—nicotine dependence	8.5e-05	0.000678	CbGpPWpGaD
Doxepin—HTR2C—GPCR ligand binding—DRD2—nicotine dependence	8.5e-05	0.000678	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—TAS2R16—nicotine dependence	8.49e-05	0.000678	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—FGD1—nicotine dependence	8.49e-05	0.000678	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—TAS2R16—nicotine dependence	8.45e-05	0.000674	CbGpPWpGaD
Doxepin—ADRA2C—GPCR ligand binding—DRD2—nicotine dependence	8.26e-05	0.000659	CbGpPWpGaD
Doxepin—HTR2B—GPCR downstream signaling—OPRM1—nicotine dependence	8.23e-05	0.000657	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—TAS2R16—nicotine dependence	8.22e-05	0.000656	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—FGD1—nicotine dependence	8.22e-05	0.000656	CbGpPWpGaD
Doxepin—HTR6—Signaling by GPCR—OPRM1—nicotine dependence	8.19e-05	0.000654	CbGpPWpGaD
Doxepin—CHRM5—GPCR downstream signaling—OPRM1—nicotine dependence	8.15e-05	0.00065	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—FGD1—nicotine dependence	8.13e-05	0.000649	CbGpPWpGaD
Doxepin—HRH4—Signaling Pathways—OPRM1—nicotine dependence	8.13e-05	0.000649	CbGpPWpGaD
Doxepin—ADRA1B—GPCR ligand binding—DRD2—nicotine dependence	8.13e-05	0.000649	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—TAS2R16—nicotine dependence	8.09e-05	0.000646	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—AKR1B10—nicotine dependence	7.95e-05	0.000635	CbGpPWpGaD
Doxepin—CHRM4—Signaling by GPCR—OPRM1—nicotine dependence	7.73e-05	0.000616	CbGpPWpGaD
Doxepin—HRH2—Signaling by GPCR—DRD2—nicotine dependence	7.72e-05	0.000616	CbGpPWpGaD
Doxepin—ADRA1D—GPCR downstream signaling—OPRM1—nicotine dependence	7.66e-05	0.000611	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—FGD1—nicotine dependence	7.65e-05	0.00061	CbGpPWpGaD
Doxepin—ABCB1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	7.6e-05	0.000606	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—AKR1B10—nicotine dependence	7.5e-05	0.000599	CbGpPWpGaD
Doxepin—HTR2B—Signaling by GPCR—OPRM1—nicotine dependence	7.48e-05	0.000597	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—TAS2R16—nicotine dependence	7.46e-05	0.000595	CbGpPWpGaD
Doxepin—CHRM5—Signaling by GPCR—OPRM1—nicotine dependence	7.4e-05	0.00059	CbGpPWpGaD
Doxepin—HTR2A—GPCR ligand binding—DRD2—nicotine dependence	7.38e-05	0.000589	CbGpPWpGaD
Doxepin—HRH1—GPCR ligand binding—DRD2—nicotine dependence	7.36e-05	0.000587	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—TAS2R16—nicotine dependence	7.34e-05	0.000586	CbGpPWpGaD
Doxepin—CHRM1—GPCR ligand binding—DRD2—nicotine dependence	7.34e-05	0.000586	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—TAS2R16—nicotine dependence	7.32e-05	0.000584	CbGpPWpGaD
Doxepin—CHRM3—GPCR ligand binding—DRD2—nicotine dependence	7.31e-05	0.000584	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—WASF2—nicotine dependence	7.31e-05	0.000583	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—TAS2R16—nicotine dependence	7.3e-05	0.000582	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—TAS2R16—nicotine dependence	7.28e-05	0.000581	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—AKR1B10—nicotine dependence	7.26e-05	0.000579	CbGpPWpGaD
Doxepin—CHRM2—GPCR ligand binding—DRD2—nicotine dependence	7.24e-05	0.000578	CbGpPWpGaD
Doxepin—ADRA1A—GPCR ligand binding—DRD2—nicotine dependence	7.22e-05	0.000576	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—TAS2R16—nicotine dependence	7.21e-05	0.000575	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—AKR1B10—nicotine dependence	7.19e-05	0.000573	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—TAS2R16—nicotine dependence	7.19e-05	0.000573	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—WASF1—nicotine dependence	7.01e-05	0.000559	CbGpPWpGaD
Doxepin—ADRA1D—Signaling by GPCR—OPRM1—nicotine dependence	6.96e-05	0.000555	CbGpPWpGaD
Doxepin—ADRA2B—GPCR downstream signaling—OPRM1—nicotine dependence	6.91e-05	0.000552	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—FGD1—nicotine dependence	6.9e-05	0.000551	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—AKR1B10—nicotine dependence	6.76e-05	0.000539	CbGpPWpGaD
Doxepin—ADRA2A—GPCR ligand binding—DRD2—nicotine dependence	6.71e-05	0.000536	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—TAS2R16—nicotine dependence	6.68e-05	0.000533	CbGpPWpGaD
Doxepin—HTR1A—GPCR downstream signaling—OPRM1—nicotine dependence	6.68e-05	0.000533	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—FGD1—nicotine dependence	6.67e-05	0.000532	CbGpPWpGaD
Doxepin—HTR2C—GPCR downstream signaling—OPRM1—nicotine dependence	6.64e-05	0.00053	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—FGD1—nicotine dependence	6.63e-05	0.000529	CbGpPWpGaD
Doxepin—HTR6—GPCR downstream signaling—DRD2—nicotine dependence	6.52e-05	0.00052	CbGpPWpGaD
Doxepin—ADRA2C—GPCR downstream signaling—OPRM1—nicotine dependence	6.46e-05	0.000515	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—FGD1—nicotine dependence	6.45e-05	0.000515	CbGpPWpGaD
Doxepin—ADRA1B—GPCR downstream signaling—OPRM1—nicotine dependence	6.36e-05	0.000507	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—FGD1—nicotine dependence	6.35e-05	0.000507	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—CYP2A7—nicotine dependence	6.33e-05	0.000506	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—OPRM1—nicotine dependence	6.31e-05	0.000503	CbGpPWpGaD
Doxepin—ADRA2B—Signaling by GPCR—OPRM1—nicotine dependence	6.28e-05	0.000501	CbGpPWpGaD
Doxepin—CHRM4—GPCR downstream signaling—DRD2—nicotine dependence	6.15e-05	0.000491	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—AKR1B10—nicotine dependence	6.1e-05	0.000487	CbGpPWpGaD
Doxepin—HTR1A—Signaling by GPCR—OPRM1—nicotine dependence	6.06e-05	0.000484	CbGpPWpGaD
Doxepin—HTR2C—Signaling by GPCR—OPRM1—nicotine dependence	6.03e-05	0.000481	CbGpPWpGaD
Doxepin—HTR2B—GPCR downstream signaling—DRD2—nicotine dependence	5.95e-05	0.000475	CbGpPWpGaD
Doxepin—HTR6—Signaling by GPCR—DRD2—nicotine dependence	5.92e-05	0.000472	CbGpPWpGaD
Doxepin—CHRM5—GPCR downstream signaling—DRD2—nicotine dependence	5.89e-05	0.00047	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—AKR1B10—nicotine dependence	5.89e-05	0.00047	CbGpPWpGaD
Doxepin—HRH4—Signaling Pathways—DRD2—nicotine dependence	5.88e-05	0.000469	CbGpPWpGaD
Doxepin—ADRA2C—Signaling by GPCR—OPRM1—nicotine dependence	5.87e-05	0.000468	CbGpPWpGaD
Doxepin—DRD2—GPCR downstream signaling—OPRM1—nicotine dependence	5.86e-05	0.000468	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—AKR1B10—nicotine dependence	5.86e-05	0.000467	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—FGD1—nicotine dependence	5.85e-05	0.000467	CbGpPWpGaD
Doxepin—ADRA1B—Signaling by GPCR—OPRM1—nicotine dependence	5.77e-05	0.000461	CbGpPWpGaD
Doxepin—HTR2A—GPCR downstream signaling—OPRM1—nicotine dependence	5.77e-05	0.00046	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—FGD1—nicotine dependence	5.76e-05	0.00046	CbGpPWpGaD
Doxepin—HRH1—GPCR downstream signaling—OPRM1—nicotine dependence	5.75e-05	0.000459	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—FGD1—nicotine dependence	5.75e-05	0.000459	CbGpPWpGaD
Doxepin—CHRM1—GPCR downstream signaling—OPRM1—nicotine dependence	5.74e-05	0.000458	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—FGD1—nicotine dependence	5.73e-05	0.000457	CbGpPWpGaD
Doxepin—CHRM3—GPCR downstream signaling—OPRM1—nicotine dependence	5.72e-05	0.000456	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—FGD1—nicotine dependence	5.71e-05	0.000456	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—AKR1B10—nicotine dependence	5.7e-05	0.000455	CbGpPWpGaD
Doxepin—CHRM2—GPCR downstream signaling—OPRM1—nicotine dependence	5.66e-05	0.000452	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—FGD1—nicotine dependence	5.65e-05	0.000451	CbGpPWpGaD
Doxepin—ADRA1A—GPCR downstream signaling—OPRM1—nicotine dependence	5.65e-05	0.000451	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—FGD1—nicotine dependence	5.64e-05	0.00045	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—AKR1B10—nicotine dependence	5.61e-05	0.000447	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—CYP2A7—nicotine dependence	5.61e-05	0.000447	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—WASF2—nicotine dependence	5.6e-05	0.000447	CbGpPWpGaD
Doxepin—CHRM4—Signaling by GPCR—DRD2—nicotine dependence	5.59e-05	0.000446	CbGpPWpGaD
Doxepin—ADRA1D—GPCR downstream signaling—DRD2—nicotine dependence	5.54e-05	0.000442	CbGpPWpGaD
Doxepin—HTR2B—Signaling by GPCR—DRD2—nicotine dependence	5.4e-05	0.000431	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—WASF1—nicotine dependence	5.37e-05	0.000429	CbGpPWpGaD
Doxepin—CHRM5—Signaling by GPCR—DRD2—nicotine dependence	5.35e-05	0.000427	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—OPRM1—nicotine dependence	5.32e-05	0.000425	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—WASF2—nicotine dependence	5.29e-05	0.000422	CbGpPWpGaD
Doxepin—ADRA2A—GPCR downstream signaling—OPRM1—nicotine dependence	5.25e-05	0.000419	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—FGD1—nicotine dependence	5.24e-05	0.000418	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—OPRM1—nicotine dependence	5.24e-05	0.000418	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—OPRM1—nicotine dependence	5.23e-05	0.000417	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—OPRM1—nicotine dependence	5.21e-05	0.000416	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—OPRM1—nicotine dependence	5.19e-05	0.000414	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—AKR1B10—nicotine dependence	5.17e-05	0.000413	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—CYP2A7—nicotine dependence	5.15e-05	0.000411	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—OPRM1—nicotine dependence	5.14e-05	0.00041	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—OPRM1—nicotine dependence	5.13e-05	0.000409	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—WASF2—nicotine dependence	5.12e-05	0.000408	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—AKR1B10—nicotine dependence	5.09e-05	0.000406	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—AKR1B10—nicotine dependence	5.08e-05	0.000405	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—WASF1—nicotine dependence	5.07e-05	0.000404	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—WASF2—nicotine dependence	5.06e-05	0.000404	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—AKR1B10—nicotine dependence	5.06e-05	0.000404	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—AKR1B10—nicotine dependence	5.04e-05	0.000402	CbGpPWpGaD
Doxepin—ADRA1D—Signaling by GPCR—DRD2—nicotine dependence	5.03e-05	0.000401	CbGpPWpGaD
Doxepin—ADRA2B—GPCR downstream signaling—DRD2—nicotine dependence	5e-05	0.000399	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—AKR1B10—nicotine dependence	4.99e-05	0.000399	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—AKR1B10—nicotine dependence	4.98e-05	0.000397	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—WASF1—nicotine dependence	4.9e-05	0.000391	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—WASF1—nicotine dependence	4.85e-05	0.000387	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—OPRM1—nicotine dependence	4.84e-05	0.000386	CbGpPWpGaD
Doxepin—HTR1A—GPCR downstream signaling—DRD2—nicotine dependence	4.83e-05	0.000385	CbGpPWpGaD
Doxepin—HTR2C—GPCR downstream signaling—DRD2—nicotine dependence	4.8e-05	0.000383	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—OPRM1—nicotine dependence	4.76e-05	0.00038	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—WASF2—nicotine dependence	4.76e-05	0.00038	CbGpPWpGaD
Doxepin—ADRA2C—GPCR downstream signaling—DRD2—nicotine dependence	4.67e-05	0.000373	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—AKR1B10—nicotine dependence	4.63e-05	0.000369	CbGpPWpGaD
Doxepin—ADRA1B—GPCR downstream signaling—DRD2—nicotine dependence	4.6e-05	0.000367	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—OPRM1—nicotine dependence	4.56e-05	0.000364	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—WASF1—nicotine dependence	4.56e-05	0.000364	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—DRD2—nicotine dependence	4.56e-05	0.000364	CbGpPWpGaD
Doxepin—ADRA2B—Signaling by GPCR—DRD2—nicotine dependence	4.54e-05	0.000362	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—OPRM1—nicotine dependence	4.42e-05	0.000352	CbGpPWpGaD
Doxepin—HTR1A—Signaling by GPCR—DRD2—nicotine dependence	4.38e-05	0.00035	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—OPRM1—nicotine dependence	4.37e-05	0.000349	CbGpPWpGaD
Doxepin—HTR2C—Signaling by GPCR—DRD2—nicotine dependence	4.36e-05	0.000348	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—WASF2—nicotine dependence	4.3e-05	0.000343	CbGpPWpGaD
Doxepin—ADRA2C—Signaling by GPCR—DRD2—nicotine dependence	4.24e-05	0.000338	CbGpPWpGaD
Doxepin—ADRA1B—Signaling by GPCR—DRD2—nicotine dependence	4.17e-05	0.000333	CbGpPWpGaD
Doxepin—HTR2A—GPCR downstream signaling—DRD2—nicotine dependence	4.17e-05	0.000333	CbGpPWpGaD
Doxepin—HRH1—GPCR downstream signaling—DRD2—nicotine dependence	4.16e-05	0.000332	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—WASF2—nicotine dependence	4.15e-05	0.000331	CbGpPWpGaD
Doxepin—CHRM1—GPCR downstream signaling—DRD2—nicotine dependence	4.15e-05	0.000331	CbGpPWpGaD
Doxepin—CHRM3—GPCR downstream signaling—DRD2—nicotine dependence	4.13e-05	0.00033	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—WASF2—nicotine dependence	4.13e-05	0.000329	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—WASF1—nicotine dependence	4.12e-05	0.000329	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—OPRM1—nicotine dependence	4.11e-05	0.000328	CbGpPWpGaD
Doxepin—CHRM2—GPCR downstream signaling—DRD2—nicotine dependence	4.09e-05	0.000327	CbGpPWpGaD
Doxepin—ADRA1A—GPCR downstream signaling—DRD2—nicotine dependence	4.08e-05	0.000326	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—WASF2—nicotine dependence	4.01e-05	0.00032	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—WASF1—nicotine dependence	3.98e-05	0.000317	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—WASF1—nicotine dependence	3.96e-05	0.000316	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—WASF2—nicotine dependence	3.95e-05	0.000315	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—WASF1—nicotine dependence	3.85e-05	0.000307	CbGpPWpGaD
Doxepin—ADRA2A—GPCR downstream signaling—DRD2—nicotine dependence	3.79e-05	0.000303	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—WASF1—nicotine dependence	3.79e-05	0.000302	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—DRD2—nicotine dependence	3.79e-05	0.000302	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—DRD2—nicotine dependence	3.78e-05	0.000301	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—DRD2—nicotine dependence	3.77e-05	0.000301	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—DRD2—nicotine dependence	3.75e-05	0.0003	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—DRD2—nicotine dependence	3.72e-05	0.000297	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—OPRM1—nicotine dependence	3.71e-05	0.000296	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—DRD2—nicotine dependence	3.71e-05	0.000296	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—CYP2A7—nicotine dependence	3.65e-05	0.000291	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—WASF2—nicotine dependence	3.64e-05	0.000291	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—WASF2—nicotine dependence	3.58e-05	0.000286	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—OPRM1—nicotine dependence	3.58e-05	0.000286	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—WASF2—nicotine dependence	3.58e-05	0.000285	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—WASF2—nicotine dependence	3.56e-05	0.000284	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—OPRM1—nicotine dependence	3.56e-05	0.000284	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—CYP2A7—nicotine dependence	3.56e-05	0.000284	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—WASF2—nicotine dependence	3.55e-05	0.000284	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—WASF2—nicotine dependence	3.52e-05	0.000281	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—WASF2—nicotine dependence	3.51e-05	0.00028	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—DRD2—nicotine dependence	3.5e-05	0.000279	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—WASF1—nicotine dependence	3.49e-05	0.000279	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—OPRM1—nicotine dependence	3.47e-05	0.000277	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—DRD2—nicotine dependence	3.44e-05	0.000275	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—WASF1—nicotine dependence	3.44e-05	0.000274	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—WASF1—nicotine dependence	3.43e-05	0.000274	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—WASF1—nicotine dependence	3.42e-05	0.000273	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—OPRM1—nicotine dependence	3.41e-05	0.000272	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—WASF1—nicotine dependence	3.41e-05	0.000272	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—WASF1—nicotine dependence	3.37e-05	0.000269	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—WASF1—nicotine dependence	3.36e-05	0.000268	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—CYP2A7—nicotine dependence	3.35e-05	0.000268	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—CYP2A7—nicotine dependence	3.32e-05	0.000265	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—DRD2—nicotine dependence	3.3e-05	0.000263	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—WASF2—nicotine dependence	3.26e-05	0.00026	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—DRD2—nicotine dependence	3.19e-05	0.000255	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—DRD2—nicotine dependence	3.16e-05	0.000252	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—OPRM1—nicotine dependence	3.14e-05	0.000251	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—WASF1—nicotine dependence	3.13e-05	0.000249	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—OPRM1—nicotine dependence	3.09e-05	0.000247	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—OPRM1—nicotine dependence	3.09e-05	0.000246	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—OPRM1—nicotine dependence	3.08e-05	0.000246	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—OPRM1—nicotine dependence	3.07e-05	0.000245	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—OPRM1—nicotine dependence	3.04e-05	0.000242	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—OPRM1—nicotine dependence	3.03e-05	0.000242	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—DRD2—nicotine dependence	2.97e-05	0.000237	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—CYP2A7—nicotine dependence	2.84e-05	0.000227	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—OPRM1—nicotine dependence	2.81e-05	0.000225	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—DRD2—nicotine dependence	2.68e-05	0.000214	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—DRD2—nicotine dependence	2.59e-05	0.000207	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—DRD2—nicotine dependence	2.58e-05	0.000206	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—DRD2—nicotine dependence	2.51e-05	0.0002	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—DRD2—nicotine dependence	2.47e-05	0.000197	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—DRD2—nicotine dependence	2.24e-05	0.000178	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—DRD2—nicotine dependence	2.23e-05	0.000178	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—DRD2—nicotine dependence	2.22e-05	0.000178	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—DRD2—nicotine dependence	2.22e-05	0.000177	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—DRD2—nicotine dependence	2.2e-05	0.000175	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—CYP2A7—nicotine dependence	2.19e-05	0.000175	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—DRD2—nicotine dependence	2.19e-05	0.000175	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—DRD2—nicotine dependence	2.03e-05	0.000162	CbGpPWpGaD
